On the contrary, LCN2 expression was reduced in AD patients with lymph node involvement in comparison with those without lymph node metastasis (P < 0.009), and similar expression level in ADSCC patients irrespective of lymph node involvement (Table S1). This evidence concerns the gene LCN2 and Alzheimer disease.